Home » Biomarkers and the Complex Diagnosis of Alzheimer's Disease: Amyloid-PET Imaging in Clinical Practice
Biomarkers and the Complex Diagnosis of Alzheimer's Disease: Amyloid-PET Imaging in Clinical Practice
Available until November 28, 2014
This activity is designed to meet the educational needs of neurologists, imaging technologists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's Disease.
This case-based enduring activity will cover the diagnosis, treatment and management of
patients with Alzheimer's disease (AD).
This CME activity is sponsored by Med Learning Group.
This activity is supported by an educational grant from Eli Lilly and Company
This program is being developed in association with the Florida Medical Association
If you have any questions regarding this activity, send an email to firstname.lastname@example.org.
Amyloid-PET Imaging in Clinical Practice — 1.0 AMA PRA Category 1™ Credit Hours